Joshua Boger, Craig Burson, John Igoe, Richard Brandywie, Jack Rybicki, Louis TM Conti, Wayne Hunter, Paul Andre, Lisa Kobialka
Massachusetts High Tech Council Names Biotech President/CEO as New Chairman
Joshua Boger, the president and CEO of Vertex Pharmaceuticals, has been named board chairman of the Massachusetts High Technology Council, which represents the state’s life sciences, defense technology and other tech-based industries.
Boger founded Vertex, the Cambridge, Mass.-based small-molecule biotech giant, in 1989. He is also chairman of BIO, the biotechnology industry's national trade organization.
From 1997 to 2006, Boger additionally served as Vertex’s chairman. Before launching Vertex, Boger was senior director of basic chemistry at Merck Sharp & Dohme Research Laboratories. Boger began his industry career at Merck in 1978.
Boger holds a BA degree in chemistry and philosophy from Wesleyan, and MSci and PhD degrees in chemistry from Harvard University.
Florida Venture Forum Elects Officers for 2008 Term
The Florida Venture Forum board of directors recently elected officers for its 2008 term:
The venture forum is a statewide group for venture capitalists and entrepreneurs created in 1984.
International Law Firm Adds Two Partners In California Expansion
International law firm King & Spalding has hired two partners from the Menlo Park, Calif., office of Perkins Coie for its new Silicon Valley office in Redwood shores (see Around the Regions, this issue). Both will specialize in intellectual property and high-technology litigation: